Tokyo Tape
Sign in

Kringle Pharma

4884.TPharmaceutical
Filed as Kringle Pharma, Inc. (2022-08–2026-05), Kringle Pharma, Inc (2023-05–2023-05)
In English · 14
Thu, Aug 27 · JST1 filing
13:085% STAKEKringle Pharma · Evo Fund + 1 joint holder · 6.01% → 4.79%−1.22pp
Fri, Jun 5 · JST1 filing
09:525% STAKEKringle Pharma · Evo Fund + 1 joint holder · 6.17% → 6.01%−0.16pp
Fri, May 29 · JST1 filing
12:485% STAKEKringle Pharma · Evo Fund + 1 joint holder · 7.39% → 6.17%−1.22pp
Mon, May 25 · JST1 filing
12:515% STAKEKringle Pharma · Evo Fund + 1 joint holder · 8.45% → 7.39%−1.06pp
Wed, May 20 · JST1 filing
13:485% STAKEKringle Pharma · Evo Fund + 1 joint holder · 9.02% → 8.45%−0.57pp
Thu, Apr 9 · JST1 filing
12:285% STAKEKringle Pharma · Evo Fund + 1 joint holder · 12.46% → 9.02%−3.44pp
Wed, Apr 8 · JST1 filing
11:205% STAKEKringle Pharma · Evo Fund + 1 joint holder · 15.35% → 12.46%−2.89pp
Wed, Mar 18 · JST1 filing
11:165% STAKEKringle Pharma · Evo Fund + 1 joint holder · 16.21% → 15.35%−0.86pp
Wed, Dec 3 · JST1 filing
14:185% STAKEKringle Pharma · Evo Fund + 1 joint holder · 17.23% → 16.21%−1.02pp
Thu, Oct 16 · JST1 filing
11:135% STAKEKringle Pharma · Evo Fund + 1 joint holder · 17.27% → 17.23%−0.04pp
Wed, Oct 15 · JST1 filing
10:175% STAKEKringle Pharma · Evo Fund + 1 joint holder · 18.24% → 17.27%−0.97pp
Wed, Sep 24 · JST1 filing
12:445% STAKEKringle Pharma · Evo Fund + 1 joint holder · 18.91% → 18.24%−0.67pp
Fri, Aug 22 · JST1 filing
12:345% STAKEKringle Pharma · Evo Fund + 1 joint holder · 19.60% → 18.91%−0.69pp
Fri, Aug 8 · JST1 filing
13:545% STAKEKringle Pharma · Evo Fund + 1 joint holder · 19.60%new 19.60%
All EDINET filings · 103
AllFinancial 195% 61Material 4Other 19
FiledDocumentFilerSource
2026-05-11CEO/CFO certificationKringle Pharma, Inc.S100Y2OF
2025-12-19CEO/CFO certificationKringle Pharma, Inc.S100XBJ2
2025-12-19Internal control reportKringle Pharma, Inc.S100XBJ6
2025-07-16Securities registrationKringle Pharma, Inc.S100WDC8
2025-05-12CEO/CFO certificationKringle Pharma, Inc.S100VQ6F
2024-12-23CEO/CFO certificationKringle Pharma, Inc.S100UZU9
2024-12-23Internal control reportKringle Pharma, Inc.S100UZUD
2024-05-13CEO/CFO certificationKringle Pharma, Inc.S100TEIQ
2024-02-09CEO/CFO certificationKringle Pharma, Inc.S100STAU
2023-12-25CEO/CFO certificationKringle Pharma, Inc.S100SJAG
2023-12-25Internal control reportKringle Pharma, Inc.S100SJAH
2023-08-23Amended securities registrationRelated to S100RPGLKringle Pharma, Inc.S100RQPZ
2023-08-18Amended securities registrationRelated to S100RPGLKringle Pharma, Inc.S100RQBA
2023-08-14Securities registrationKringle Pharma, Inc.S100RPGL
2022-12-26CEO/CFO certificationKringle Pharma, Inc.S100PVFT
2022-12-26Internal control reportKringle Pharma, Inc.S100PVF9
2021-12-27CEO/CFO certificationKringle Pharma, Inc.S100N526
2021-12-27Internal control reportKringle Pharma, Inc.S100N520
2021-10-15Securities registrationKringle Pharma, Inc.S100MLNN

EDINET catalog 2017-01-01 → 2026-10-03; earlier dates still being collected. 7 financial reports not structured yet.

Not structured yet
2022-03-31quarterlyoriginal indexedS100O1XJ
2021-12-31quarterlyoriginal indexedS100NI8G
2021-09-30annualoriginal indexedS100N50Z
2021-06-30quarterlyoriginal indexedS100MA82
2021-03-31quarterlyoriginal indexedS100LCBD
2020-12-31quarterlyoriginal indexedS100KSQI
2020-09-30annualoriginal indexedS100KGH2